Market Closed -
Nasdaq
04:00:00 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
8.96
USD
|
+0.45%
|
|
+4.19%
|
+40.66%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,114
|
751.5
|
385.7
|
367.8
|
517.7
|
-
|
-
|
Enterprise Value (EV)
1 |
1,900
|
751.5
|
385.7
|
367.8
|
517.7
|
517.7
|
517.7
|
P/E ratio
|
-37.1
x
|
-11.4
x
|
-3.67
x
|
-5.9
x
|
-9.9
x
|
-19.3
x
|
5.4
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
576
x
|
45
x
|
37.1
x
|
21.1
x
|
6.95
x
|
2.14
x
|
EV / Revenue
|
-
|
576
x
|
45
x
|
37.1
x
|
21.1
x
|
6.95
x
|
2.14
x
|
EV / EBITDA
|
-48,353,760
x
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-59,670,975
x
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-0%
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
46,294
|
51,685
|
52,268
|
57,732
|
57,779
|
-
|
-
|
Reference price
2 |
45.66
|
14.54
|
7.380
|
6.370
|
8.960
|
8.960
|
8.960
|
Announcement Date
|
3/2/21
|
3/31/22
|
3/9/23
|
4/1/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
-
|
1.304
|
8.578
|
9.905
|
24.55
|
74.49
|
242.4
|
EBITDA
|
-
|
-43.72
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
-43.92
|
-61.56
|
-79.21
|
-62.59
|
-54.38
|
-31.14
|
135.4
|
Operating Margin
|
-
|
-
|
-4,720.71%
|
-923.39%
|
-631.89%
|
-221.49%
|
-41.8%
|
55.86%
|
Earnings before Tax (EBT)
1 |
-
|
-43.82
|
-61.85
|
-108.9
|
-61.12
|
-56.1
|
-17.2
|
135.6
|
Net income
1 |
-
|
-43.82
|
-61.8
|
-105.2
|
-60.78
|
-54.28
|
-31.04
|
104.4
|
Net margin
|
-
|
-
|
-4,739.11%
|
-1,226.89%
|
-613.59%
|
-221.08%
|
-41.66%
|
43.07%
|
EPS
2 |
-0.9000
|
-1.230
|
-1.280
|
-2.010
|
-1.080
|
-0.9050
|
-0.4650
|
1.660
|
Free Cash Flow
|
-
|
-35.42
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
7/31/20
|
3/2/21
|
3/31/22
|
3/9/23
|
4/1/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
-
|
1.304
|
1.808
|
2.2
|
2.438
|
2.132
|
2.447
|
2.582
|
2.479
|
2.397
|
4.415
|
5.35
|
6.69
|
8.05
|
7.68
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-13.48
|
-21.92
|
-20.02
|
-22.18
|
-19.83
|
-18.29
|
-16.74
|
-17.83
|
-21.99
|
-10.69
|
-15.36
|
-15.18
|
-13.15
|
-10.64
|
-13.44
|
Operating Margin
|
-
|
-1,680.6%
|
-1,107.47%
|
-1,008.32%
|
-813.33%
|
-857.88%
|
-684.02%
|
-690.59%
|
-887.17%
|
-445.85%
|
-347.9%
|
-283.64%
|
-196.56%
|
-132.17%
|
-175%
|
Earnings before Tax (EBT)
1 |
-13.47
|
-22.08
|
-21.82
|
-21.72
|
-19.52
|
-45.87
|
-11.86
|
-17.45
|
-21.48
|
-10.33
|
-16.5
|
-16.5
|
-13.2
|
-9.9
|
-
|
Net income
1 |
-13.47
|
-22.04
|
-21.67
|
-19.61
|
-19.13
|
-44.84
|
-11.76
|
-17.36
|
-21.4
|
-10.25
|
-15.31
|
-15.18
|
-13.15
|
-10.64
|
-13.44
|
Net margin
|
-
|
-1,689.8%
|
-1,198.34%
|
-891.55%
|
-784.5%
|
-2,103.05%
|
-480.63%
|
-672.5%
|
-863.37%
|
-427.53%
|
-346.77%
|
-283.64%
|
-196.56%
|
-132.17%
|
-175%
|
EPS
2 |
-0.2800
|
-0.4500
|
-0.4100
|
-0.3800
|
-0.3700
|
-0.8600
|
-0.2100
|
-0.3100
|
-0.3700
|
-0.1800
|
-0.2600
|
-0.2550
|
-0.2150
|
-0.1750
|
-0.2000
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/17/21
|
3/31/22
|
5/19/22
|
8/16/22
|
11/10/22
|
3/9/23
|
5/22/23
|
8/17/23
|
11/28/23
|
4/1/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
213
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-35.4
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
13.9
|
23.2
|
7.17
|
3.3
|
4
|
6
|
-
|
Capex / Sales
|
-
|
-
|
1,775.92%
|
83.6%
|
33.35%
|
16.29%
|
8.05%
|
-
|
Announcement Date
|
7/31/20
|
3/2/21
|
3/31/22
|
3/9/23
|
4/1/24
|
-
|
-
|
-
|
Last Close Price
8.96
USD Average target price
16
USD Spread / Average Target +78.57% Consensus |
1st Jan change
|
Capi.
|
---|
| +40.66% | 518M | | -5.77% | 14.68B | | -40.71% | 2.71B | | -12.92% | 2.44B | | -8.78% | 1.51B | | -.--% | 1.12B | | +91.79% | 502M | | +1.67% | 183M | | -.--% | 168M | | -29.34% | 161M |
Medical Imaging Systems
|